← Back to guidelines
Dermatology14 papers

Chilblain lupus erythematosus

Last edited: 4/15/2026

Overview

Chilblain lupus erythematosus, often presenting as chilblains (pernio), involves painful, red-to-purple papular lesions primarily affecting the fingers and toes due to non-freezing cold exposure. It predominantly affects younger individuals and peaks during colder months 1.

Diagnosis

  • Clinical Presentation: Painful, erythematous, or violaceous papules on acral areas (fingers, toes) 1.
  • Seasonal Occurrence: Common in winter months, particularly December to February 1.
  • Demographics: Predominantly affects children and young adults, with a notable female predominance 1.
  • Management

  • Symptomatic Treatment: Protection from cold exposure (wearing gloves, socks) 1.
  • Topical Agents: Moisturizers and emollients to prevent dryness and cracking 1.
  • Anti-inflammatory Measures: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation 1.
  • Special Populations

  • Pediatrics: Higher incidence noted in children aged 7-20 years 1.
  • Elderly: Less common, with only 6 cases in the 41-65 age group observed 1.
  • Key Recommendations

  • Advise Cold Protection Measures: Recommend wearing protective clothing (gloves, socks) to prevent cold exposure 1 (Evidence: Moderate).
  • Symptomatic Relief with NSAIDs: Use NSAIDs for managing pain and inflammation 1 (Evidence: Moderate).
  • Monitor and Educate: Educate patients, especially children and young adults, about seasonal risks and preventive strategies 1 (Evidence: Expert opinion).
  • References

    1 Pramanik T, Jha AK, Ghimire A. A retrospective study of cases presenting with chilblains (Perniosis) in Out Patient Department Of Dermatology, Nepal Medical College and Teaching Hospital (NMCTH). Nepal Medical College journal : NMCJ 2011. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG